NASDAQ:PPBT - Nasdaq - US74638P1093 - ADR - Currency: USD
2.6
+0.21 (+8.79%)
The current stock price of PPBT is 2.6 USD. In the past month the price increased by 10.64%. In the past year, price decreased by -83.9%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 53.61 | 699.12B | ||
JNJ | JOHNSON & JOHNSON | 15.44 | 373.45B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 20.08 | 317.70B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.93 | 228.64B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 16.55 | 225.80B | ||
MRK | MERCK & CO. INC. | 9.86 | 192.95B | ||
PFE | PFIZER INC | 7.32 | 133.55B | ||
SNY | SANOFI-ADR | 11.22 | 120.15B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.58 | 98.25B | ||
GSK | GSK PLC-SPON ADR | 9.26 | 83.26B | ||
ZTS | ZOETIS INC | 28.01 | 75.08B | ||
HLN | HALEON PLC-ADR | 23.16 | 51.11B |
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The firm is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
PURPLE BIOTECH LTD-ADR
4 Oppenheimer St., Science Park
Rehovot 7670104 IL
CEO: Gil Efron
Employees: 9
Phone: 97239333121
The current stock price of PPBT is 2.6 USD. The price increased by 8.79% in the last trading session.
The exchange symbol of PURPLE BIOTECH LTD-ADR is PPBT and it is listed on the Nasdaq exchange.
PPBT stock is listed on the Nasdaq exchange.
PURPLE BIOTECH LTD-ADR (PPBT) has a market capitalization of 6.89M USD. This makes PPBT a Nano Cap stock.
PURPLE BIOTECH LTD-ADR (PPBT) currently has 9 employees.
PURPLE BIOTECH LTD-ADR (PPBT) has a support level at 2.34 and a resistance level at 2.62. Check the full technical report for a detailed analysis of PPBT support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
PPBT does not pay a dividend.
PURPLE BIOTECH LTD-ADR (PPBT) will report earnings on 2025-08-14.
PURPLE BIOTECH LTD-ADR (PPBT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.67).
The outstanding short interest for PURPLE BIOTECH LTD-ADR (PPBT) is 2.48% of its float. Check the ownership tab for more information on the PPBT short interest.
ChartMill assigns a technical rating of 1 / 10 to PPBT. When comparing the yearly performance of all stocks, PPBT is a bad performer in the overall market: 94.64% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to PPBT. While PPBT seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months PPBT reported a non-GAAP Earnings per Share(EPS) of -3.67. The EPS increased by 71.43% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -19.55% | ||
ROE | -22.03% | ||
Debt/Equity | 0 |